Search
Haemonetics Corp
HAEAdd to Watchlist
85.540USD
+0.780+0.92%
Close 07-31 16:00（ET）Quotes delayed by 15 min
3.87BMarket Cap
41.47P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Haemonetics Corp is 8.18, ranking 60 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 88.00, with a high of 108.00 and a low of 62.00.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
90.778
Target Price
+6.27%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Haemonetics Corp
HAE
11
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Medtronic PLC
MDT
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Haemonetics Corp's expected revenue for the next quarter?
Haemonetics Corp's expected revenue is 327.89M.
What is Haemonetics Corp's price target?
Analysts forecast that Haemonetics Corp's price target is USD 88.00, with the highest forecast at USD 108.00 and the lowest forecast at USD 62.00.
How have Haemonetics CorpHAE's recent earnings per share performed?
The market expectation was USD -0.44, while Haemonetics CorpHAE's earnings per share (EPS) for the previous quarter was USD 0.96. EPS for the next quarter is expected at USD 1.08.
What is the analyst rating for Haemonetics Corp?
Based on the ratings of Haemonetics Corp's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.